InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NANOVIRICIDES, INC.

NNVC Clue Score36
United States Fiscal year ends June CIK 0001379006
$1.30 -0.76% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.30 −70.98% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−9.6Net income−10.3EPS, diluted−0.17Fiscal year 2018Operating income−9.3Net income−8.6EPS, diluted−0.13Fiscal year 2019Operating income−8.7Net income−8.4Fiscal year 2020Operating income−8.0Net income−13.4Fiscal year 2021Operating income−8.7Net income−8.8EPS, diluted−0.81Fiscal year 2022Operating income−8.1Net income−8.1EPS, diluted−0.70Fiscal year 2023Revenue0.0Operating income−8.9Net income−8.6EPS, diluted−0.74Fiscal year 2024Revenue0.0Operating income−8.5Net income−8.3EPS, diluted−0.70Fiscal year 2025Revenue0.0Operating income−9.6Net income−9.5EPS, diluted−0.63Fiscal year 2026Revenue0.0Operating income−8.3Net income−8.2EPS, diluted−0.41
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue n/a n/a n/a n/a n/a n/a 0.0 0.0 0.0 0.0
Growth
Operating income −9.6 −9.3 −8.7 −8.0 −8.7 −8.1 −8.9 −8.5 −9.6 −8.3
Net income −10.3 −8.6 −8.4 −13.4 −8.8 −8.1 −8.6 −8.3 −9.5 −8.2
Growth
EPS, diluted −0.17 −0.13 n/a n/a −0.81 −0.70 −0.74 −0.70 −0.63 −0.41

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−7.9Capital expenditure−0.2Free cash flow−8.1Fiscal year 2018Operating cash flow−7.8Capital expenditure−0.2Free cash flow−8.0Fiscal year 2019Operating cash flow−6.8Capital expenditure−0.1Free cash flow−6.9Fiscal year 2020Operating cash flow−6.7Capital expenditure−0.0Free cash flow−6.7Fiscal year 2021Operating cash flow−8.2Capital expenditure−0.2Free cash flow−8.5Fiscal year 2022Operating cash flow−5.9Capital expenditure−0.3Free cash flow−6.2Fiscal year 2023Operating cash flow−5.7Capital expenditure−0.2Free cash flow−5.8Fiscal year 2024Operating cash flow−6.3Capital expenditure−0.2Free cash flow−6.5Fiscal year 2025Operating cash flow−8.5Capital expenditure−0.1Free cash flow−8.5Fiscal year 2026Operating cash flow−7.7Capital expenditure−0.1Free cash flow−7.8
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −7.9 −7.8 −6.8 −6.7 −8.2 −5.9 −5.7 −6.3 −8.5 −7.7
Capital expenditure −0.2 −0.2 −0.1 −0.0 −0.2 −0.3 −0.2 −0.2 −0.1 −0.1
Free cash flow −8.1 −8.0 −6.9 −6.7 −8.5 −6.2 −5.8 −6.5 −8.5 −7.8
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash15.1Shareholders’ equity20.3Fiscal year 2018Cash7.1Shareholders’ equity17.7Fiscal year 2019Cash2.6Shareholders’ equity10.6Fiscal year 2020Cash13.7Shareholders’ equity21.8Fiscal year 2021Cash20.5Shareholders’ equity29.9Fiscal year 2022Cash14.1Shareholders’ equity23.1Fiscal year 2023Cash8.1Shareholders’ equity14.9Fiscal year 2024Cash4.8Shareholders’ equity11.5Fiscal year 2025Cash1.6Shareholders’ equity7.5Fiscal year 2026Cash2.8Shareholders’ equity8.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 15.1 7.1 2.6 13.7 20.5 14.1 8.1 4.8 1.6 2.8
Shareholders’ equity 20.3 17.7 10.6 21.8 29.9 23.1 14.9 11.5 7.5 8.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2021† 30 Jun 2021 FY2022 30 Jun 2022 FY2023 30 Jun 2023 FY2024 30 Jun 2024 FY2025 30 Jun 2025 FY2026 30 Jun 2026
Revenue and profit
n/a n/a n/a n/a n/a n/a 0.0 0.0 0.0 0.0
Growth
6.6 5.9 5.9 4.7 6.1 5.8 6.4 5.4 5.5 4.7
3.0 3.4 2.7 3.3 2.6 2.3 2.6 3.1 4.0 3.6
−9.6 −9.3 −8.7 −8.0 −8.7 −8.1 −8.9 −8.5 −9.6 −8.3
Growth
−10.3 −8.6 −8.4 −13.4 −8.8 −8.1 n/a n/a n/a −8.2
0.0 0.0 0.0 0.0 n/a n/a n/a n/a n/a n/a
−10.3 −8.6 −8.4 −13.4 −8.8 −8.1 −8.6 −8.3 −9.5 −8.2
Growth
Per share
−0.17 −0.13 n/a n/a −0.81 −0.70 −0.74 −0.70 −0.63 −0.41
−0.17 −0.13 n/a n/a −0.81 −0.70 −0.74 −0.70 −0.63 −0.41
Growth
60.1 64.9 n/a n/a 10.9 11.5 11.6 11.9 15.1 20.2
60.1 64.9 n/a n/a 10.9 11.5 11.6 11.9 15.1 20.2
Growth +8.0% +5.8% +0.8% +2.1% +27.3% +33.5%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.